Cohen Veterans Bioscience

4 articles with Cohen Veterans Bioscience

• Cohen Veterans Bioscience Joins PRISM 2 Consortium

  6/23/2021

  Brain research and advocacy non-profit Cohen Veterans Bioscience ​ (CVB) announced today that it joined the PRISM 2 consortium as as a designated associated partner of the Innovative Medicines Initiative (IMI).

• 

  Research Roundup: Predicting COVID-19 Cytokine Storm and More

  10/23/2020

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

• New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric Disorders

  10/19/2020

  - A new connectome-based diagnosis solution may help identify patient subtypes that best respond to therapy in individuals with post-traumatic stress disorder or major depressive disorder -

• Cohen Veterans Bioscience Launches New Veterans Advisory Council (VAC) To Address Brain Health Priorities

  2/13/2020

  VAC Unveils Initial Agenda for More Effective Treatment of Active Service Members & Veterans with Brain Trauma